000

ILYANGPHARM(1P)

No trades
See on Supercharts
Market capitalization
‪251.60 B‬KRW
‪−2.51 B‬KRW
‪370.54 B‬KRW
‪12.29 M‬
Beta (1Y)
0.35

About ILYANGPHARM(1P)

CEO
Dong-Yeon Kim
Headquarters
Yongin-si
Employees (FY)
641
Founded
1946
ISIN
KR7007571003
FIGI
BBG000BJV9J1
Il-Yang Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. It operates through the following business divisions: Specialty Meidicine, Over-the-counter Medicine, Export, and Others. Its products include ethical and over-the counter drugs under the brand names of NolTec, Supect, and Wonbi-D. The company was founded on July 1, 1946 and is headquartered in Yongin-si, South Korea.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 007575 is 15420 KRW — it has increased by 0.19% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange ILYANGPHARM(1P) stocks are traded under the ticker 007575.
007575 stock is 0.19% volatile and has beta coefficient of 0.35. Check out the list of the most volatile stocks — is ILYANGPHARM(1P) there?
Yes, you can track ILYANGPHARM(1P) financials in yearly and quarterly reports right on TradingView.
007575 stock has risen by 1.58% compared to the previous week, the month change is a 4.12% rise, over the last year ILYANGPHARM(1P) has showed a 20.10% decrease.
007575 net income for the last quarter is ‪−7.38 B‬ KRW, while the quarter before that showed ‪4.83 B‬ KRW of net income which accounts for −252.71% change. Track more ILYANGPHARM(1P) financial stats to get the full picture.
Today ILYANGPHARM(1P) has the market capitalization of ‪248.37 B‬, it has decreased by 1.95% over the last week.
Yes, 007575 dividends are paid annually. The last dividend per share was 175.00 KRW. As of today, Dividend Yield (TTM)% is 1.09%. Tracking ILYANGPHARM(1P) dividends might help you take more informed decisions.
Like other stocks, 007575 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ILYANGPHARM(1P) stock right from TradingView charts — choose your broker and connect to your account.
007575 reached its all-time high on Jul 21, 2020 with the price of 167000 KRW, and its all-time low was 1150 KRW and was reached on May 19, 2004.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 641.00 employees. See our rating of the largest employees — is ILYANGPHARM(1P) on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ILYANGPHARM(1P) technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ILYANGPHARM(1P) stock shows the sell signal. See more of ILYANGPHARM(1P) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ILYANGPHARM(1P) EBITDA is ‪33.19 B‬ KRW, and current EBITDA margin is 8.96%. See more stats in ILYANGPHARM(1P) financial statements.